Roche has licensed an antibody-drug conjugate (ADC) designed to treat advanced small-cell lung cancer from China-based Innovent Biologics for $80 million up front and up to $1 billion in milestone ...
Coupled with the fact that the automobile industry usually takes early vacations before the Spring Festival, the effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback